Liminatus Pharma Warrants (LIMNW) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 89 145 sessions, September 9, 2025 to September 9, 2026
- Largest daily move
- +266.3% close of February 3, 2026
- 1-year change
- -80.1% closing prices, September 9, 2025 to September 9, 2026
Company Description
Liminatus Pharma Warrants (NASDAQ: LIMNW) is classified in the biological products, (no diagnostic substances) industry.
LIMNW has declined 80.1% over the past year. The last closing price was $0.0437.
For FY2025, Liminatus Pharma Warrants and diluted earnings per share of -$0.43.
This page collects what Stock Titan holds for LIMNW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Liminatus Pharma Warrants (LIMNW) closed at $0.0437 on September 9, 2026. Over the past 12 months, the price has lost 80.1%.
LIMNW Metrics & Rankings
Price returns through September 9, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Liminatus Pharma Warrants has filed 5 recent SEC filings, including 4 Form 8-K, 1 Form 10-Q. The most recent filing was submitted on August 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LIMNW SEC filings →
Financial Highlights
Diluted earnings per share stood at -$0.43. With a current ratio of 0.05, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Liminatus Pharma Warrants (LIMNW) currently stands at 6.6 thousand shares, up 92.9% from the previous reporting period. Since September 2025, short interest has increased by 1916.5%.
Days to Cover History
Days to cover for Liminatus Pharma Warrants (LIMNW) currently stands at 2.1 days, down 35.6% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 115% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 3.3 days.
LIMNW Company Profile & Sector Positioning
Liminatus Pharma Warrants (LIMNW) and is listed on the NASDAQ.